Alaunos Therapeutics, Inc. Shareholders' Equity
Alaunos Therapeutics, Inc. (TCRT) had Shareholders' Equity of $652.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent $652.00K.
- 2026-03-31: Stockholders' Equity Attributable to Parent $1.29M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $2.15M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $2.80M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $652.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.29M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $2.15M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.80M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $3.66M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $1.06M 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $2.06M 10-Q · filed 2026-05-15 | |
| 2024-09-30 | $2.72M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $3.77M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $4.80M 10-Q · filed 2025-08-14 | $4.80M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $6.31M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $13.90M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $21.65M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $29.51M 10-Q · filed 2024-08-14 | |
| 2022-12-31 | $38.55M 10-K · filed 2025-03-31 | |
| 2022-09-30 | $32.11M 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $40.18M 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $49.12M 10-Q · filed 2023-08-14 | |
| 2021-12-31 | $58.06M 10-K · filed 2024-04-01 | |
| 2021-09-30 | $68.71M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $88.28M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $105.64M 10-Q · filed 2022-08-15 | |
| 2020-12-31 | $123.98M 10-K · filed 2023-03-07 | |
| 2020-09-30 | $144.92M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $163.41M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $180.34M 10-Q · filed 2021-08-13 | |
| 2019-12-31 | $95.01M 10-K · filed 2022-03-30 | |
| 2019-09-30 | $106.13M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $61.99M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $74.22M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $85.56M 10-K · filed 2021-03-01 | |
| 2018-09-30 | -$156.41M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$139.24M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | -$123.15M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | -$96.81M 10-K · filed 2021-03-01 | |
| 2017-09-30 | -$79.80M 10-Q · filed 2017-11-06 | |
| 2017-06-30 | -$64.27M 10-Q · filed 2017-07-31 | |
| 2017-03-31 | -$94.90M 10-Q · filed 2017-05-01 | |
| 2016-12-31 | -$77.30M 10-K · filed 2020-03-02 | |
| 2016-09-30 | -$64.42M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$51.99M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $77.81M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $87.37M 10-K · filed 2019-03-05 | |
| 2015-09-30 | $93.84M 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $110.44M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $120.60M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $33.84M 10-K · filed 2018-03-01 | |
| 2014-09-30 | $36.48M 10-Q · filed 2014-10-30 | |
| 2014-06-30 | $37.72M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $41.73M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $49.38M 10-K · filed 2017-02-16 | |
| 2013-09-30 | $3.63M 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $19.33M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $37.89M 10-Q · filed 2013-05-07 | |
| 2012-12-31 | $48.45M 10-K · filed 2016-02-24 | |
| 2012-09-30 | $59.03M 10-Q · filed 2012-11-08 | |
| 2012-06-30 | $75.64M 10-Q/A · filed 2012-08-28 | |
| 2012-03-31 | $97.70M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $71.61M 10-K · filed 2015-02-26 | |
| 2011-09-30 | $84.11M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $84.13M 10-Q/A · filed 2011-08-09 | |
| 2010-12-31 | $30.55M 10-K · filed 2014-03-03 | |
| 2010-09-30 | $42.20M 10-Q · filed 2011-08-01 | |
| 2009-12-31 | $28.10M 10-K · filed 2014-03-03 | |
| 2008-12-31 | $6.74M 10-K · filed 2014-03-03 | |
| 2007-12-31 | $30.37M 10-K · filed 2014-03-03 | |
| 2006-12-31 | $26.53M 10-K · filed 2014-03-03 | |
| 2005-12-31 | $7.20M 10-K · filed 2014-03-03 | |
| 2004-12-31 | -$144.00K 10-K · filed 2014-03-03 | |
| 2003-12-31 | $340.00K 10-K · filed 2014-03-03 | |
| 2003-09-09 | $500.00K 10-K · filed 2014-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |